← 返回

丝胶蛋白的抗氧化和免疫调节活性及其在肿瘤预防和治疗中的应用

英文原题:Antioxidant and immunomodulatory activities of sericin and its applications in tumor prevention and treatment.

查看英文原题

Antioxidant and immunomodulatory activities of sericin and its applications in tumor prevention and treatment.

PubMed 2026/06/15(内容时间) Am J Transl Res Q3 · IF 1.8(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

丝胶是丝绸加工的副产品,因其优异的抗氧化和免疫调节特性,在肿瘤预防和治疗方面展现出巨大潜力。其结构富含极性氨基酸,赋予丝胶高亲水性和生物相容性,使其能够通过清除活性氧、调节 PI3K/Akt 通路及自噬相关通路来抑制癌细胞增殖并诱导凋亡。在复杂的肿瘤微环境中,丝胶作为有效的免疫调节剂发挥作用。它并非诱导广泛的免疫抑制,而是通过减轻促肿瘤性慢性炎症,并可能保留或间接增强NK 细胞的细胞溶解活性,从而调节免疫微环境。通过平衡巨噬细胞反应并缓解氧化应激诱导的免疫耗竭,丝胶有助于恢复免疫监视。丝胶的抗肿瘤作用并非通过非特异性免疫激活实现,而是通过恢复氧化还原稳态和重塑炎症环境,从而将肿瘤微环境从促癌状态转变为有利于免疫监视的状态。作为天然抗氧化剂和药物递送载体,丝胶在联合放化疗以及纳米技术赋能的诊断和治疗系统中展现出靶向递送和低毒性的潜力。

然而,在其广泛临床应用之前,与稳定性和生产可扩展性相关的问题仍需解决。

展开英文摘要原文

Sericin, a by-product of silk processing, shows great potential in tumor prevention and treatment owing to its excellent antioxidant and immunomodulatory properties. Its structure, which is rich in polar amino acids, endows sericin with high hydrophilicity and biocompatibility, allowing it to suppress cancer cell proliferation and induce apoptosis by scavenging reactive oxygen species and modulating the PI3K/Akt pathway and autophagy-related pathways. In the complex tumor microenvironment, sericin acts as an effective immune modulator. Instead of inducing widespread immunosuppression, it modulates the immune microenvironment by attenuating pro-tumorigenic chronic inflammation and potentially preserving or indirectly enhancing the cytolytic activity of natural killer cells.

By balancing macrophage responses and alleviating oxidative stress-induced immune exhaustion, sericin helps restore immune surveillance. The antitumor effect of sericin is not achieved through nonspecific immune activation, but rather by restoring redox homeostasis and reshaping the inflammatory environment, thereby transforming the tumor microenvironment from a pro-cancer state to one conducive to immune surveillance.

As a natural antioxidant and drug delivery carrier, sericin shows potential for targeted delivery and low toxicity in combined chemoradiotherapy and nanotechnology-enabled diagnostic and therapeutic systems.

However, issues related to stability and production scalability still need to be addressed before its widespread clinical application.

论文信息

作者
Chen S、Lv P、Yang F、Ding D、Deng Y、Gao Y、He L
第一作者单位
Department of Otolaryngology, Head and Neck Surgery, Affiliated Hospital of North Sichuan Medical College Nanchong 637000, Sichuan, China.China
通讯作者单位
Department of Pathology, Affiliated Hospital of North Sichuan Medical College Nanchong 637000, Sichuan, China.China
文献类型
综述
期刊
American journal of translational research2026
原文标识
PubMed 42491157 · DOI 10.62347/HONO1844